Braskem Evaluates Court Protection As R$10.3 Billion Loss Triggers Going Concern Warning
- Braskem, Latin America's largest petrochemical company, is evaluating court protection against creditors in Brazil - or potentially full bankruptcy - after its financial position deteriorated sharply
- The company reported R$10.3 billion ($1.8 billion) in Q4 losses - double the prior year - and issued a going concern warning, saying it may not be able to meet future debt obligations
- The company owes $1.5 billion in payments this year against $2.1 billion in cash, while IG4 Capital's takeover from Novonor awaits EU antitrust approval unlikely before May
Braskem, the largest petrochemical producer in Latin America, is considering filing for Braskem creditor protection through a medida cautelar - a temporary court shield against creditors under Brazilian law - according to sources involved in the negotiations. Full bankruptcy is also being evaluated, though no final decision has been made and plans could still change.
The company's financial deterioration accelerated in the fourth quarter. Braskem reported losses of R$10.3 billion ($1.8 billion) - double the previous year's figure - and issued a going concern warning in its Q4 earnings release, stating that its results "indicate the existence of material uncertainty that may cast significant doubt on the company's ability to continue as a going concern."
The Cash CrunchBraskem must pay $1.5 billion in debt obligations in 2026. As of December, the company held approximately $2.1 billion in cash - a buffer that appears adequate on paper but narrows rapidly when set against ongoing operating losses, the Maceió salt mine remediation costs, and a global petrochemical market that remains depressed.
The worsening cash position is what pushed management to evaluate the cautelar - a legal mechanism that would temporarily freeze creditor actions while the company explores restructuring alternatives. Unlike a full judicial recovery (recuperação judicial), a cautelar provides breathing room without committing to a formal restructuring plan immediately.
The IG4 Takeover in LimboComplicating the picture is the pending change of control. Fund IG4 Capital has been waiting for European antitrust approval to acquire Braskem from Novonor SA (formerly Odebrecht), but that clearance is not expected until May at the earliest. Until the ownership transfer closes, strategic decisions remain constrained by the uncertainty over who will ultimately control the company.
Novonor has been trying to divest Braskem for years, following the Lava Jato corruption scandal that engulfed the conglomerate. Multiple sale attempts have failed, and the petrochemical downturn has eroded the asset's value with each passing year. IG4's acquisition was supposed to resolve the ownership impasse - but Braskem's finances may force a restructuring before the deal closes.
Mexico Subsidiary Also in DistressSeparately, Braskem's Mexican joint venture, Braskem Idesa, is negotiating with creditors to secure financing for a potential Chapter 11 filing in the United States. The subsidiary faces its own cash pressures in a Mexican petrochemical market that has been hit by weaker demand and rising feedstock costs.
What It Means for MarketsA Braskem creditor protection filing would be one of Brazil's largest corporate distress events in recent years. The company sits at the intersection of multiple stress points: the Selic at 14.75% makes refinancing expensive, the Iran-driven oil shock has disrupted petrochemical margins, and the equity market window that might have offered an exit is closed. For investors tracking Brazilian credit risk, Braskem is now the corporate name to watch.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment